Upcoming Event: Ask Anything About Lung Cancer

From June 26 to 27, lung cancer expert David M. Jackman, MD, will answer patient-submitted questions as a moderator on the social media cancer Web site CancerConnect. Dr. Jackman is a thoracic oncologist at Dana-Farber Cancer Institute in Boston. According to CancerConnect, “his research interests include evaluating how to predict responses to targeted therapy in non-small cell lung cancer (NSCLC).” Questions can be submitted here.

Dr. Tenenbaum to Speak as Panel Host for The Scientist Magazine's Webinar Series

On Tuesday, May 7, Dr. Tenenbaum will host a panel in The Scientists three-part webinar series Decoding DNA: New Twists and Turns. The series, which began on April 18, takes “a bold look at what the future holds for DNA research, bringing together senior investigators and key leaders in the field of genetics and genomics.” Dr. Tenenbaum will speak during the final webinar, The Impact of Personalized Medicine.

From The Scientist‘s description:

“After the human genome was sequenced, Personalized Medicine became an end goal, driving both academia and the pharma/biotech industry to find and target cellular pathways and drug therapies that are unique to an individual patient. The final webinar in the series will help us better understand The Impact of Personalized Medicine, what we can expect to gain and where we stand to lose.”

Dr. Tenenbaum will be joined by Amy P. Abernethy, M.D., Associate Professor of Medicine, Duke University School of Medicine and Director of the Duke Cancer Care Research Program; and Abhijit “Ron” Mazumder, Ph.D., Global Head, Research & Product Development, Janssen Diagnostics, Janssen Pharmaceutical companies of Johnson and Johnson.

When: Tuesday, May 7, 2013, 2:30–4:00 pm ET. Register here.